Novandi Chemistry is currently operating a near-normal service, with only minor disruption due to flexible working arrangements for our staff. All our projects are currently on-track and we are accepting new work from existing and new customers. Should the situation change, we will update accordingly.
THK-5117 is a novel patented Positron Emission Tomography (PET) radiotracer that has been developed by researchers at Tohoku University (Japan). THK-5117 labels neurofibrillary tangles/tau pathology with high selectivity and through an exclusive agreement with Clino Ltd (Japan), Novandi Chemistry can now offer tritium labelled [3H]THK-5117 to the scientific community. PET imaging of neurofibrillary tangles [...]
AZD2184 is a clinically tested Positron Emission Tomography (PET) radiotracer with enhanced imaging properties. The higher signal-to-background signal of AZD2184 compared with PIB (Pittsburgh compound B) renders [3H]AZD2184 higher sensitivity and is an ideal radioligand for in vitro binding studies and visualization of amyloid plaques. Through an exclusive agreement with Navidea Biopharmaceuticals (Ohio, USA), Novandi Chemistry [...]